Navamedic ASA (OSL:NAVA)
18.75
-0.05 (-0.27%)
May 15, 2026, 10:04 AM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 450.85 million as of May 14, 2026. Its market cap has increased by 19.84% in one year.
Market Cap
450.85M
Enterprise Value
588.49M
Revenue
571.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.75
Market Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 450.85M, an increase of 303.64%. That is a compound annual growth rate of 7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 450.85M | -21.01% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.32B |
| Circio Holding ASA | 2.67B |
| Nordhealth AS | 1.99B |
| Photocure ASA | 1.68B |
| Lytix Biopharma ASA | 815.14M |
| Omda AS | 789.55M |
| Gentian Diagnostics ASA | 615.25M |
| Zelluna ASA | 556.92M |